The Registration and Regulatory Affairs Department at Al Hayat Scientific Office plays a critical role in ensuring timely access to high-quality pharmaceutical products across Iraq. With a strong track record in regulatory excellence, we have successfully registered 53  manufacturing sites and 148 pharmaceutical products, reinforcing our deep understanding of the Ministry of Health’s requirements and international standards.

Our regulatory team combines expertise, precision, and well-established relationships with health authorities to navigate Iraq’s evolving regulatory landscape. From dossier preparation to final approval, we ensure every product meets the highest standards of safety, efficacy, and compliance.

By streamlining the registration process and upholding rigorous quality standards, we help our global partners bring essential treatments to the Iraqi market—ensuring that patients receive safe, effective therapies without delay.